Back to Journals » Pharmacogenomics and Personalized Medicine » Volume 13
Original Research
CYP2C19*17 May Increase the Risk of Death Among Patients with an Acute Coronary Syndrome and Non-Valvular Atrial Fibrillation Who Receive Clopidogrel and Rivaroxaban
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
6,152 | Dovepress* | 5,148+ | 864 | 6,012 | |
PubMed Central* | 1,004 | 242 | 1,246 | ||
Totals | 6,152 | 1,106 | 7,258 | ||
*Since 23 January 2020 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
2 | 0 | 0 | 0 | 1 | 1 |
View citations on PubMed Central and Google Scholar